Catalyst Pharmaceuticals Inc

CPRX NASDAQ Healthcare & Biotech United States US14888U1016
31.49 $

Catalyst Pharmaceuticals Inc develops and commercializes drugs for the treatment of rare and complex neurological diseases, including myasthenia gravis.